<DOC>
	<DOC>NCT01279954</DOC>
	<brief_summary>The purpose of this study is to assess the safety and efficacy of abatacept in the treatment of uveitis.</brief_summary>
	<brief_title>Abatacept in the Treatment of Uveitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>patients with visionthreatening autoimmune uveitis failure to respond to prednisone and at least one other systemic immunosuppressive, or intolerance to such medications due to side effects serious concomitant illness that could interfere with the subject's participation</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>